Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 14Carcinoma, Non-Small-Cell Lung 5Prostatic Neoplasms 4Lung Neoplasms 3Stomach Neoplasms 2Esophageal Neoplasms 2Breast Neoplasms, Male 2Uterine Neoplasms 1Thrombosis 1Peritoneal Neoplasms 1Pathological and Imaging Examinations Confirmed Metastatic Prostate Cancer 1Pancreatic Neoplasms 1Non-squamous Non-small Cell Lung Cancer 1Non-Muscle Invasive Bladder Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1NSCLC 1Inflammatory Breast Neoplasms 1Infections 1Hypopharyngeal Neoplasms 1Hormone Refractory Prostate Cancer 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Drug-Related Side Effects and Adverse Reactions 1Carcinogenesis 1Breast Neoplasm Female 1Breast Diseases 1Amenorrhea 1Adenocarcinoma 1

Interventions

Exercise 2pyrotinib 1palbociclib 1Trastuzumab 1Tomography, X-Ray Computed 1Surveys and Questionnaires 1Surgimend 1Paclitaxel 1Mammaplasty 1Liquid Biopsy 1Fentanyl 1Epirubicin 1Educational Status 1Docetaxel 1Cyclophosphamide 1Cryotherapy 1Cholecalciferol 1Carboplatin 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Diseases × Docetaxel × Clear all
NCT03756064 2019-08-13

Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

Zhejiang Cancer Hospital

Phase NA Unknown
100 enrolled
Breast

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡